Thermo Fisher Scientific Inc (USD)
TMO
Overview
Key Information
Legal Documents
Financials

Overview

SectorHealthcare
Industry-
Day Range362.00 | 369.82
52-Wk Range- | -
Last Close-
Mkt Cap (m)-
Dividend yield-
ISINUS8835561023
Volume1,127,751.00
Exchange VenueNYS

Company Profile

Thermo Fisher Scientific Inc is a healthcare company. It offers analytical instruments, laboratory equipment, software, services, consumables, reagents and chemicals.

Key Information
Price/Earning-
Price/Book-
Price/Sales-
P/CF-
Rev Growth (3 year avg)11.81
EPS Growth (3 year avg)0.22
Operating Margin % 16.37
Net Margin %14.47
Return on Equity12.91
Debt/Equity0.60

Documents

Prospectus
en 31/03/2020
Annual Report
en 31/12/2019

Please refer to the below issuer website for further documents.

https://www.thermofisher.com

Financials

Income Statement
USD201420152016201720182019
Revenue (m)16,889.6016,965.4018,274.1020,918.0024,358.0025,542.00
Operating Income (m)1,904.802,451.502,638.403,065.003,833.004,181.00
Net Income (m)1,894.401,975.402,021.802,225.002,938.003,696.00
Basic EPS4.764.965.125.647.319.24
Avg. Diluted Shares Outstanding (m)402.30401.90397.40398.00406.00403.00
Balance Sheet
USD201420152016201720182019
Current Assets (m)6,539.805,741.207,021.009,421.0010,625.0011,893.00
Non Current Assets (m)36,312.3035,147.8038,886.5047,248.0045,607.0046,488.00
Total Assets (m)42,852.1040,889.0045,907.5056,669.0056,232.0058,381.00
Current Liabilities (m)5,349.804,147.304,865.807,048.006,147.006,197.00
Total Liabilities (m)------
Total Equity (m)20,548.1021,350.2021,539.3025,413.0027,586.0029,675.00
Cash Flows
USD201420152016201720182019
Operating Cash Flows (m)2,619.602,816.903,156.304,005.004,543.004,973.00
Capital Expenditure (m)-427.60-422.90-444.40-508.00-758.00-926.00
Figures are quoted in USD unless stated otherwise
$
365.89
Last Price